Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bailly

Showing results (181-190 of 361) with videos related to

Pageof 37
Sort By:
Molecular Pharmacology|January 28, 1998
Recognition of specific sequences in DNA by a topoisomerase I inhibitor derived from the antitumor drug rebeccamycinC Bailly, P Colson, C Houssier, et al.
Nucleic Acids Research|October 16, 1999
DNA cleavage by hydroxy-salicylidene-ethylendiamine-iron complexesS Routier, H Vezin, E Lamour, et al.
Anti-Cancer Drug Design|March 1, 1996
Sequence-specific binding of antitumour bisquaternary ammonium heterocycles to DNA and inhibition of polymerase activity in vitroL Kittler, U Wähnert, B C Baguley, et al.
Biochemical and Biophysical Research Communications|April 29, 1988
DNA-binding and DNA-cleaving properties of a synthetic model AGAGLU related to the antitumour drugs AMSA and bleomycinC Bailly, A Kenani, N Helbecque, et al.
Biochemistry|July 7, 1999
The camptothecin-resistant topoisomerase I mutant F361S is cross-resistant to antitumor rebeccamycin derivatives. A model for topoisomerase I inhibition by indolocarbazolesC Bailly, C Carrasco, F Hamy, et al.
Bioorganic & Medicinal Chemistry|July 31, 1999
Inhibition of HIV-1 Tat-TAR interaction by diphenylfuran derivatives: effects of the terminal basic side chainsN Gelus, C Bailly, F Hamy, et al.
Molecular Pharmacology|March 1, 1997
Copper-dependent oxidative and topoisomerase II-mediated DNA cleavage by a netropsin/4'-(9-acridinylamino)methanesulfon-m-anisidide combilexinJ P Henichart, M J Waring, J F Riou, et al.
Biochemistry|September 28, 1998
Optimization of alternate-strand triple helix formation at the 5'CpG3' and 5'GpC3' junction stepsC Marchand, J S Sun, C Bailly, et al.
Molecular Pharmacology|February 3, 1999
Enhanced binding to DNA and topoisomerase I inhibition by an analog of the antitumor antibiotic rebeccamycin containing an amino sugar residueC Bailly, X Qu, F Anizon, et al.
Plos One|March 8, 2013
A novel W1999S mutation and non-target site resistance impact on acetyl-CoA carboxylase inhibiting herbicides to varying degrees in a UK Lolium multiflorum populationShiv Shankhar Kaundun, Geraldine C Bailly, Richard P Dale, et al.
Pageof 37

Showing results (181-190 of 361) with videos related to

Sort By:
Pageof 37
Molecular Pharmacology|January 28, 1998
Recognition of specific sequences in DNA by a topoisomerase I inhibitor derived from the antitumor drug rebeccamycinC Bailly, P Colson, C Houssier, et al.
Nucleic Acids Research|October 16, 1999
DNA cleavage by hydroxy-salicylidene-ethylendiamine-iron complexesS Routier, H Vezin, E Lamour, et al.
Anti-Cancer Drug Design|March 1, 1996
Sequence-specific binding of antitumour bisquaternary ammonium heterocycles to DNA and inhibition of polymerase activity in vitroL Kittler, U Wähnert, B C Baguley, et al.
Biochemical and Biophysical Research Communications|April 29, 1988
DNA-binding and DNA-cleaving properties of a synthetic model AGAGLU related to the antitumour drugs AMSA and bleomycinC Bailly, A Kenani, N Helbecque, et al.
Biochemistry|July 7, 1999
The camptothecin-resistant topoisomerase I mutant F361S is cross-resistant to antitumor rebeccamycin derivatives. A model for topoisomerase I inhibition by indolocarbazolesC Bailly, C Carrasco, F Hamy, et al.
Bioorganic & Medicinal Chemistry|July 31, 1999
Inhibition of HIV-1 Tat-TAR interaction by diphenylfuran derivatives: effects of the terminal basic side chainsN Gelus, C Bailly, F Hamy, et al.
Molecular Pharmacology|March 1, 1997
Copper-dependent oxidative and topoisomerase II-mediated DNA cleavage by a netropsin/4'-(9-acridinylamino)methanesulfon-m-anisidide combilexinJ P Henichart, M J Waring, J F Riou, et al.
Biochemistry|September 28, 1998
Optimization of alternate-strand triple helix formation at the 5'CpG3' and 5'GpC3' junction stepsC Marchand, J S Sun, C Bailly, et al.
Molecular Pharmacology|February 3, 1999
Enhanced binding to DNA and topoisomerase I inhibition by an analog of the antitumor antibiotic rebeccamycin containing an amino sugar residueC Bailly, X Qu, F Anizon, et al.
Plos One|March 8, 2013
A novel W1999S mutation and non-target site resistance impact on acetyl-CoA carboxylase inhibiting herbicides to varying degrees in a UK Lolium multiflorum populationShiv Shankhar Kaundun, Geraldine C Bailly, Richard P Dale, et al.
Pageof 37